8-K: Danimer Scientific Faces NYSE Delisting Notice After Share Price Falls Below $1

Danimer Scientific has received a notice from the NYSE for failing to maintain a minimum average share price of $1.00 over a 30-day period.

Summary

• Danimer Scientific was notified by the NYSE on May 21, 2024, that it is not in compliance with continued listing standards.
• The company's average closing share price fell below $1.00 over a consecutive 30 trading-day period, ending May 20, 2024.
• Danimer Scientific intends to cure this deficiency and regain compliance with NYSE listing requirements.
• To regain compliance, the company's common stock must have a closing share price of at least $1.00 on the last trading day of any month within the next six months, and an average closing share price of at least $1.00 over the 30 trading-day period ending on that last day.
• The company's stock will continue to trade on the NYSE during this period, provided it meets other listing requirements.
• The NYSE notification does not impact the company's business operations, SEC reporting, or debt obligations.

Sentiment

Score: 3

Explanation: The document indicates a significant negative event (delisting notice) due to a low share price, which is concerning for investors. While the company intends to regain compliance, the situation is unfavorable.

Positives

• The company has notified the NYSE of its intent to cure the deficiency.
• The company's stock will continue to trade on the NYSE during the six-month compliance period.
• The delisting notice does not affect the company's business operations, SEC reporting, or debt obligations.

Negatives

• The company's share price has fallen below the NYSE's minimum average closing price requirement of $1.00.
• The company is at risk of being delisted from the NYSE if it does not regain compliance within six months.

Risks

• There is a risk that the company may not be able to increase its share price to meet the NYSE's compliance requirements within the six-month period.
• Failure to regain compliance could result in the company's stock being delisted from the NYSE, which could negatively impact investor confidence and the company's ability to raise capital.

Future Outlook

The company has six months to regain compliance with NYSE listing requirements by achieving a $1.00 closing share price and average price at the end of any month.

Management Comments

• The Company has notified the NYSE of its intent to cure the deficiency and return to compliance with the NYSE continued listing requirements.

Industry Context

This delisting notice highlights the challenges faced by companies with volatile stock prices and the importance of maintaining compliance with exchange listing requirements. It is not uncommon for companies to face delisting notices when their share price falls below minimum thresholds.

Comparison to Industry Standards

• Many companies in the materials and chemical sector have faced similar delisting risks due to market volatility and financial performance issues.
• Companies like Amyris and Origin Materials have also experienced significant stock price fluctuations, highlighting the challenges in this sector.
• The NYSE has specific listing requirements that all listed companies must adhere to, and failure to do so can result in delisting.

Stakeholder Impact

• Shareholders may experience a decline in the value of their investment due to the delisting notice.
• The company's ability to raise capital may be negatively impacted if it is delisted.
• Employees may be concerned about the company's future prospects.

Next Steps

• The company must achieve a closing share price of at least $1.00 on the last trading day of any month within the next six months.
• The company must also maintain an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month.
• The company will continue to trade on the NYSE during this compliance period.

Key Dates

Keywords

delisting, NYSE, share price, compliance, listing requirements, DNMR